Remedy: Things will start to happen in less than a year

By Atte Riikola
We have examined our assumptions about Remedy’s game projects and cost structure, which resulted in our earnings estimates for 2023 declining, but our longer-term estimates that determine the direction of the company's investment story remain unchanged. In 2023, Remedy is still clearly in an investment phase as the company builds its strategy for the next growth leap with 5 major gaming projects under development. However, the company's investment story is entering an interesting phase in less than a year with the launch of Alan Wake 2, which is also a key short-term driver for the share.